GH - Guardant Health, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Guardant Health, Inc.
IPO Date: October 1, 2018
Sector: Healthcare
Industry: Diagnostics and Research
Market Cap: $22.59B
Activated in VL: True
Average Daily Range
Avg Daily Range: $2.03 | 3.11%
Avg Daily Range (30 D): $3.57 | 2.08%
Avg Daily Range (90 D): $4.02 | 2.59%
Institutional Daily Volume
Avg Daily Volume: 1.37M
Avg Daily Volume (30 D): 1.54M
Avg Daily Volume (90 D): 1.78M
Trade Size
Avg Trade Size (Sh.): 67
Avg Trade Size (Sh.) (30 D): 49
Avg Trade Size (Sh.) (90 D): 51
Institutional Trades
Total Institutional Trades: 13,538
Avg Institutional Trade: $3.25M
Avg Institutional Trade (30 D): $7.67M
Avg Institutional Trade (90 D): $7.77M
Avg Institutional Trade Volume: .05M
Avg Institutional Trades (Per Day): 6
Market Closing Trades
Avg Closing Trade: $10.43M
Avg Closing Trade (30 D): $51.96M
Avg Closing Trade (90 D): $62.48M
Avg Closing Volume: 151.88K
 
News
Sep 7, 2026 @ 12:41 PM
AstraZeneca Secures FDA Nod for New Breast Cancer ...
Source: Na
Aug 27, 2026 @ 5:00 PM
Global Blood-Based Biomarkers Market to Witness Up...
Source: Delveinsight
Aug 25, 2026 @ 12:54 PM
State of the Life Sciences Industry to Be Reviewed...
Source: Bcc Research
Jul 22, 2026 @ 8:49 AM
Global Cancer Biomarkers Market to Reach $37.8 Bil...
Source: Researchandmarkets.Com
Jun 19, 2026 @ 9:39 AM
Ovarian Cancer Diagnostics Market Size to Reach US...
Source: Sns Insider
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-3.51 $-.9 $-.85
Diluted EPS $-3.51 $-.9 $-.85
Revenue $1.18B $334.98M $301.67M
Gross Profit $769.16M $219.03M $196.75M
Net Income / Loss $-453.44M $-120.14M $-112.08M
Operating Income / Loss $-470.26M $-129.12M $-121.35M
Cost of Revenue $413.95M $115.95M $104.92M
Net Cash Flow $431.77M $66.3M $612.02M
PE Ratio